NL-OMON27582尚未招募不适用
The effect of inhaled glycopyrronium bromide on excessive sialorrhea and drooling in Parkinson Disease: a dose finding study
Medisch Spectrum Twente, Enschede0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
入排标准
入选标准
- •Diagnosed with Parkinson disease
- •Moderate to severe sialorrhea, defined as a minimum of 4 of the Mier scale
排除标准
- •Hypersensitivity to glycopyrronium or other excipients
- •Use of medication with known anticholinergic effects.
研究者
相似试验
已完成
2 期
The effect of INhaled Glycopyrronium bromide on Excessive Sialorrhea and Drooling in Parkinson disease: a dose finding studyNL-OMON45524Medisch Spectrum Twente10
招募中
2 期
Effects of glycopirronium inhalation therapy evaluated by change of physical activity for untreated chronic obstructive pulmonary disease (COPD) patients.Chronic Obstructive Pulmonary Disease (COPD)JPRN-UMIN000014303Department of Respiratory Medicine, Osaka Police Hospital22
已完成
2 期
The effect of glycopyrronium bromide on hypersalivation in patients with Parkinson's disease: a randomised, cross-over, double-blind, placebo controlled trial.NL-OMON30532Medisch Spectrum Twente24
进行中（未招募）
2 期
An investigation into how adding an inhaled steroid to COPD treatment may potentially protect against heart disease.Chronic Obstructive Airways Disease [COPD]RespiratoryISRCTN29148209Hull University Teaching Hospitals NHS Trust40
尚未招募
不适用
Efficacy of Glycopyrronium added to Budesonide/Formoterol in patients with Asthma-COPD overlap syndromepatients with Asthma-COPD overlap syndromJPRN-UMIN000026651Toyama City Hospital15